CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 2802 [2018-00824]

Download as PDF 2802 Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued Regulation citation Number of respondents Form name Responses per respondent Total responses Average burden per response (in hours) Total burden hours Missing Report Form .......... 29 1 29 .08 3 ............................................. 6,059,761 ........................ 6,059,761 ........................ 326,120 Total ............................. HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–00825 Filed 1–18–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Centers for Disease Control and Prevention (CDC)/ Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will hold a public meeting. DATES: February 22, 2018, 2:00 p.m. to 4:00 p.m. ET. ADDRESSES: This teleconference meeting will accommodate up to 100 attendees. Parties may access the teleconference by dialing 888–989–6421 and using participant code 9874492. Participants should call and connect 15-minutes prior to the start of the meeting. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment should daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:05 Jan 18, 2018 Jkt 244001 contact CDR Holly Berilla, Senior Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR Holly Berilla, Senior Public Health Analyst, HRSA/HAB/ DPD, 5600 Fishers Lane, 09N156, Rockville, Maryland 20857; (2) call 301– 443–9965; or (3) send an email to hberilla@hrsa.gov. SUPPLEMENTARY INFORMATION: The CDC/ HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment was established under Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as amended. The purpose of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment is to advise the Secretary, HHS; the Director, CDC; and the Administrator, HRSA regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STDs; prevention and treatment efforts including surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional eduction, patient healthcare delivery, and prevention services; Agency policies about prevention of HIV, viral hepatitis and other STDs; treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the Agencies in their developoment of responses to emerging health needs related to HIV, viral hepatitis, and other STDs. Information about the Committee and the meeting agenda is available by contacting CDR Holly Berilla at the contact information above. During the meeting, the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will discuss workgroup reports and updates, information PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 regarding the National Ryan White HIV/ AIDS Program Conference, and Committee business-related items. Agenda items are subject to change as priorities dictate. Due to the nature and time limitations of the meeting, members of the public will not have an opportunity to provide oral comments, although written comments may be submitted to CDR Holly Berilla at the contact information listed above at least 10 days prior to the meeting. Individuals who need special assistance should notify CDR Holly Berilla at the contact information listed above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–00824 Filed 1–18–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Statement of Organization, Functions, and Delegations of Authority Office for Civil Rights, Office of the Secretary, HHS. SUMMARY: This notice establishes the Conscience and Religious Freedom Division in the Office for Civil Rights of the Department of Health and Human Services. SUPPLEMENTARY INFORMATION: In accordance with Executive Order 13798 Promoting Free Speech and Religious Liberty (May 4, 2017), 82 FR 21675, and the Attorney General’s Guidance on Federal Law Protections for Religious Liberty (October 6, 2017), Part A, Office of the Secretary, Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (HHS), as last amended at 81 FR 95622 (December 28, 2016), is being amended at Chapter AT, Office for Civil Rights (OCR) to reflect the restructuring of OCR as follows: I. Under Chapter AT, Office for Civil Rights (OCR), in the outline section AGENCY: E:\FR\FM\19JAN1.SGM 19JAN1

Agencies

[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00824]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Centers for Disease Control and Prevention 
(CDC)/Health Resources and Services Administration (HRSA) Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will 
hold a public meeting.

DATES: February 22, 2018, 2:00 p.m. to 4:00 p.m. ET.

ADDRESSES: This teleconference meeting will accommodate up to 100 
attendees. Parties may access the teleconference by dialing 888-989-
6421 and using participant code 9874492. Participants should call and 
connect 15-minutes prior to the start of the meeting.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment should contact CDR Holly Berilla, Senior 
Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS 
Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR 
Holly Berilla, Senior Public Health Analyst, HRSA/HAB/DPD, 5600 Fishers 
Lane, 09N156, Rockville, Maryland 20857; (2) call 301-443-9965; or (3) 
send an email to [email protected].

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 
217a], as amended.
    The purpose of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment is to advise the Secretary, 
HHS; the Director, CDC; and the Administrator, HRSA regarding 
objectives, strategies, policies, and priorities for HIV, viral 
hepatitis, and other STDs; prevention and treatment efforts including 
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, 
and related behaviors; epidemiologic, behavioral, health services, and 
laboratory research on HIV, viral hepatitis, and other STDs; 
identification of policy issues related to HIV/viral hepatitis/STD 
professional eduction, patient healthcare delivery, and prevention 
services; Agency policies about prevention of HIV, viral hepatitis and 
other STDs; treatment, healthcare delivery, and research and training; 
strategic issues influencing the ability of CDC and HRSA to fulfill 
their missions of providing prevention and treatment services; 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to the Agencies in their developoment of 
responses to emerging health needs related to HIV, viral hepatitis, and 
other STDs. Information about the Committee and the meeting agenda is 
available by contacting CDR Holly Berilla at the contact information 
above.
    During the meeting, the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment will discuss workgroup 
reports and updates, information regarding the National Ryan White HIV/
AIDS Program Conference, and Committee business-related items. Agenda 
items are subject to change as priorities dictate.
    Due to the nature and time limitations of the meeting, members of 
the public will not have an opportunity to provide oral comments, 
although written comments may be submitted to CDR Holly Berilla at the 
contact information listed above at least 10 days prior to the meeting. 
Individuals who need special assistance should notify CDR Holly Berilla 
at the contact information listed above at least 10 days prior to the 
meeting.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-00824 Filed 1-18-18; 8:45 am]
 BILLING CODE 4165-15-P